Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
Phase 3
Completed
- Conditions
- Acne Rosacea
- Registration Number
- NCT00041977
- Lead Sponsor
- CollaGenex Pharmaceuticals
- Brief Summary
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Milton S. Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States
David Pariser, MD
🇺🇸Norfolk, Virginia, United States
Beer and Houck/Florida Dermatology Institute
🇺🇸West Palm Beach, Florida, United States
University of Miami Medical Center
🇺🇸Miami, Florida, United States
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
University of Louisville
🇺🇸Louisville, Kentucky, United States
University of Florida
🇺🇸Gainesville, Florida, United States